Blueprint Medicines (BPMC) Stock Chart & Stock Price History → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free BPMC Stock Alerts $107.00 +12.14 (+12.80%) (As of 05/2/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Blueprint Medicines Stock Price Performance5 Day Performance+15.05%1 Month Performance+16.01%3 Month Performance+34.46%6 Month Performance+79.02%Year-To-Date Performance+16.00%1 Year Performance+106.25% Receive BPMC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Blueprint Medicines and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchUrgent dollar warningYour 2024 Election Money Blueprint Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today.Find out for free here. BPMC Stock Chart for Friday, May, 3, 2024 BPMC Chart by TradingView Blueprint Medicines Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2024$94.86$107.00+12.80%$110.16$100.912.00 million shs$6.55 billion05/01/2024$91.34$94.86+3.85%$96.40$90.85883,382 shs$5.81 billion04/30/2024$93.10$91.34-1.89%$93.00$90.75529,234 shs$5.59 billion04/29/2024$93.00$93.10+0.11%$94.91$91.12622,933 shs$5.70 billion04/26/2024$90.73$93.00+2.50%$94.98$90.47725,952 shs$5.69 billion04/25/2024$92.26$90.73-1.66%$91.46$88.46755,177 shs$5.55 billion Get the Latest News and Ratings for BPMC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Blueprint Medicines and its competitors with MarketBeat's FREE daily newsletter. 04/24/2024$92.29$92.26-0.03%$93.74$90.43588,540 shs$5.65 billion04/23/2024$90.61$92.29+1.85%$94.67$89.19788,709 shs$5.65 billion04/22/2024$86.85$90.61+4.33%$92.66$86.52792,073 shs$5.55 billion04/19/2024$88.90$86.85-2.31%$89.90$84.62813,144 shs$5.32 billion04/18/2024$88.38$88.90+0.59%$91.76$86.56734,926 shs$5.44 billion04/17/2024$86.09$88.38+2.66%$89.69$86.78728,290 shs$5.41 billion04/16/2024$85.18$86.09+1.07%$88.08$84.44410,706 shs$5.27 billion04/15/2024$87.25$85.18-2.37%$87.84$84.38506,375 shs$5.21 billion04/12/2024$92.25$87.25-5.42%$93.00$87.06484,715 shs$5.34 billion04/11/2024$90.49$92.25+1.94%$92.56$90.44404,250 shs$5.65 billion04/10/2024$92.20$90.49-1.85%$90.58$84.55569,818 shs$5.54 billion04/09/2024$91.54$92.20+0.72%$93.93$91.34710,321 shs$5.64 billion04/08/2024$91.65$91.54-0.12%$93.21$90.57435,421 shs$5.60 billion04/05/2024$90.68$91.65+1.07%$91.76$88.23485,632 shs$5.61 billion04/04/2024$92.23$90.68-1.68%$93.31$90.63700,458 shs$5.55 billion04/03/2024$91.56$92.23+0.73%$93.36$90.31583,269 shs$5.64 billion04/02/2024$96.42$91.56-5.04%$94.49$90.50565,099 shs$5.60 billion04/01/2024$94.86$96.42+1.64%$96.99$93.70604,803 shs$5.90 billion03/29/2024$94.86$94.86$95.98$93.50659,240 shs$5.81 billion03/28/2024$94.79$94.86+0.07%$95.98$93.50646,740 shs$5.81 billion03/27/2024$89.67$94.79+5.71%$94.91$89.12796,359 shs$5.80 billion03/26/2024$88.22$89.67+1.64%$92.55$88.26544,645 shs$5.49 billion03/25/2024$87.04$88.22+1.36%$89.58$86.76337,034 shs$5.40 billion03/22/2024$90.05$87.04-3.34%$91.06$87.03709,059 shs$5.33 billion03/21/2024$88.26$90.05+2.03%$91.81$89.13778,464 shs$5.51 billion03/20/2024$87.97$88.26+0.33%$89.53$84.811.28 million shs$5.40 billion03/19/2024$86.82$87.97+1.32%$89.45$84.901.57 million shs$5.38 billion03/18/2024$90.50$86.82-4.07%$91.67$86.10996,788 shs$5.31 billion03/15/2024$87.71$90.50+3.18%$90.75$86.581.19 million shs$5.54 billion03/14/2024$90.60$87.71-3.19%$90.82$86.36516,690 shs$5.37 billion03/13/2024$89.70$90.60+1.00%$92.25$89.40537,302 shs$5.55 billion03/12/2024$89.47$89.70+0.26%$90.44$87.04482,059 shs$5.49 billion03/11/2024$92.30$89.47-3.07%$92.82$88.67530,276 shs$5.48 billion03/08/2024$92.04$92.30+0.28%$94.72$91.93673,401 shs$5.65 billionThe AI stock to buy right now (Ad)There are about 350,000 large corporations worldwide. Can you see the potential for this AI company to grow like crazy?Click Here to Get the AI Stock Name03/07/2024$90.38$92.04+1.84%$92.74$89.731.47 million shs$5.64 billion03/06/2024$89.67$90.38+0.79%$91.78$88.92785,259 shs$5.53 billion03/05/2024$90.80$89.67-1.24%$90.84$88.55601,940 shs$5.49 billion03/04/2024$95.12$90.80-4.54%$95.69$90.39625,025 shs$5.56 billion03/01/2024$93.52$95.12+1.71%$98.06$93.73780,008 shs$5.82 billion02/29/2024$95.45$93.52-2.02%$98.82$92.95716,581 shs$5.73 billion02/28/2024$99.79$95.45-4.35%$101.00$95.27960,286 shs$5.84 billion02/27/2024$95.05$99.79+4.99%$99.87$95.001.73 million shs$6.11 billion02/26/2024$89.49$95.05+6.21%$95.57$89.371.29 million shs$5.82 billion02/23/2024$86.00$89.49+4.06%$91.19$86.62881,228 shs$5.48 billion02/22/2024$87.26$86.00-1.44%$88.92$80.421.74 million shs$5.27 billion02/21/2024$91.25$87.26-4.37%$92.50$86.471.09 million shs$5.34 billion02/20/2024$90.26$91.25+1.10%$92.83$88.981.10 million shs$5.59 billion02/19/2024$90.26$90.26$94.47$88.821.13 million shs$5.53 billion02/16/2024$87.57$90.26+3.07%$94.47$88.821.09 million shs$5.49 billion02/15/2024$76.80$87.57+14.02%$89.25$77.691.64 million shs$5.32 billion02/14/2024$73.17$76.80+4.96%$77.37$72.24840,439 shs$4.67 billion02/13/2024$77.54$73.17-5.64%$75.71$72.46881,005 shs$4.45 billion02/12/2024$76.54$77.54+1.31%$78.78$76.63644,113 shs$4.71 billion02/09/2024$74.16$76.54+3.21%$77.34$74.33509,111 shs$4.65 billion02/08/2024$74.20$74.16-0.05%$75.93$72.73864,802 shs$4.51 billion02/07/2024$77.17$74.20-3.85%$77.38$73.691.45 million shs$4.51 billion02/06/2024$76.66$77.17+0.67%$77.58$75.40693,418 shs$4.69 billion02/05/2024$79.58$76.66-3.67%$78.91$76.14581,826 shs$4.66 billion02/02/2024$79.88$79.58-0.38%$79.81$77.70365,992 shs$4.84 billion Related Companies: APLS Stock Chart IONS Stock Chart BBIO Stock Chart OGN Stock Chart CYTK Stock Chart ELAN Stock Chart PRGO Stock Chart NUVL Stock Chart ALPN Stock Chart ITCI Stock Chart Receive BPMC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Blueprint Medicines and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BPMC) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetry$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blueprint Medicines Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.